Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/30/2008 | CN101168054A Fishes infectious spleen and kidney necrosis virus gene engineering vaccine and preparation method thereof |
04/30/2008 | CN101168049A Application of interleukin-22 in preparing medicine for treating hepatopathy and preparation method thereof |
04/30/2008 | CN100385006C Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
04/30/2008 | CN100385004C Cold shock inducible expression and production of heterologous polypeptides |
04/30/2008 | CN100385003C Production method of recombinant fusion protein of human serum albumin-interferon alpha 2b |
04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
04/30/2008 | CN100385001C Recombinant bacillus phytases and uses thereof |
04/30/2008 | CN100385000C Application of true halophyte cytoplasma membrane water channel protein genes |
04/30/2008 | CN100384999C Salt tolerant, drought resistance, and cold proof gene of transcriptional factor in DREB class of poplar adjusted and controlled by code, and application |
04/30/2008 | CN100384998C Method for preparing recombinant goose interleukin-2 protein and its application |
04/30/2008 | CN100384997C Lefteye flounder disease resistance related MHC gene marker and subsidiary breeding method |
04/30/2008 | CN100384996C Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same |
04/30/2008 | CN100384995C Transformed silkworm producing human collagen |
04/30/2008 | CN100384990C Method for constructing non-virulent strain of infectious bursal disease virus |
04/30/2008 | CN100384986C Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
04/30/2008 | CN100384984C Process for producing L-lysine by fermenting |
04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
04/30/2008 | CN100384878C Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
04/30/2008 | CN100384877C Antibody ('11c7') anti nogo a and its pharmaceutical use |
04/30/2008 | CN100384875C 蛋白质 Protein |
04/30/2008 | CN100384873C Chimeric antagonist ANTH1 |
04/30/2008 | CN100384871C Isolated fluorescent protein from clytia gregaria CGFP and use thereof |
04/30/2008 | CN100384870C Fat metabolic regulation-related transcription factor GmDofA and its coding gene and use |
04/30/2008 | CN100384481C Blastocyst implantation related factor and its uses |
04/30/2008 | CN100384480C Delivery system for nucleic acids |
04/30/2008 | CA2606589A1 Prostate cancer field effect analysis methods and kits |
04/29/2008 | US7365253 Wheat variety YW03W |
04/29/2008 | US7365248 Celery named ADS-2 |
04/29/2008 | US7365247 Method of large scale mutagenesis in tomato plants |
04/29/2008 | US7365242 Suppression of specific classes of soybean seed protein genes |
04/29/2008 | US7365241 Seed specific USP promoters for expressing genes in plants |
04/29/2008 | US7365240 Nucleic acids encoding anthelmintic agents and plants made therefrom |
04/29/2008 | US7365189 Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis |
04/29/2008 | US7365187 Performing PCR using a sense primer and an antisense primer, in the presence of an additional sense primer comprising the sense primer and an oligodeoxyribonucleotide having a first additional sequence and ligated to the 5' end of the sense primer and an additional antisense primer |
04/29/2008 | US7365186 for genetically engineered plants with increased lignin production using regulatory sequences isolated from Eucalyptus grandis capable of initiating and promoting the transcription of polynucleotides in plant cells undergoing xylogenesis |
04/29/2008 | US7365184 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
04/29/2008 | US7365183 Sequence-determined DNA fragments encoding SRF-type transcription factor proteins |
04/29/2008 | US7365182 Comprises nucleotide sequences coding vernalization independence polypeptides (VIP) for contolling the time of flowering in agriculure important crop plants such as tomatoes, corn and lettuce |
04/29/2008 | US7365181 Probes for chondrogenesis |
04/29/2008 | US7365180 Enzymes that bind to and/or depolymerize cellulose; food, beer, wine, animal feeds, textile production and laundering, pulp and paper industry, and agricultural industries |
04/29/2008 | US7365179 Solid phase support for use in genomic analysis; gene expression analysis; high throughput assay; genotyping |
04/29/2008 | US7365177 Expression vector comprising nucleotide sequences which code chromogenic protein for use in transformation and generation of fish animal models of disease |
04/29/2008 | US7365175 Wit 3.0, a novel gene to control soft tissue wound healing |
04/29/2008 | US7365171 Chemotactic cytokine for use in diagnosis, prevention and treatment of tumors |
04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
04/29/2008 | US7365169 T-bet antibodies |
04/29/2008 | US7365164 Screening method for genes of brewing yeast |
04/29/2008 | US7365163 Isolation nulceic acid; genetic engineering; screening antagonist; aminobutyric acid receptor; diagnostics for detecting aberrant GABAA receptor epsilon subunit (GABRE) and ET2 expression, therapy of disorders involving ET2 and GABRE |
04/29/2008 | US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use |
04/29/2008 | US7365161 Mutant tyrosine repressor which does not require tyrosine to induce expression of the tyrosine phenol-lyase gene |
04/29/2008 | US7365160 Membrane protein for use as diagnostic tool in detection and screening of xenobiotics; drug screening |
04/29/2008 | US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
04/29/2008 | US7365158 Antiproliferative agents; anticancer agents |
04/29/2008 | US7365157 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological disorders |
04/29/2008 | US7365132 For the synthesis of polymers which are useful as supports in solid phase organic synthesis |
04/29/2008 | US7365058 Diabetes; DNA or RNA molecules comprising at least ten contiguous bases having a sequence in a pancreatic islet microRNA |
04/29/2008 | US7365052 Tendon-inducing methods |
04/29/2008 | US7365051 Compounds with improved cartilage-inducing and/or bone-inducing activity |
04/29/2008 | US7364910 Methods of inducing ovulation |
04/29/2008 | US7364903 Cell lines that stably or transiently express a functional umami (T1R1/T1R3) taste receptor |
04/29/2008 | US7364902 Mobilization of viral genomes from T-DNA using site-specific recombination systems |
04/29/2008 | US7364901 Recombinant Stokesia epoxygenase gene |
04/29/2008 | US7364899 Appartus for use in monitoring migration of biopolymers |
04/29/2008 | US7364897 Methods and devices for performing chemical reactions on a solid support |
04/29/2008 | US7364894 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
04/29/2008 | US7364893 infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene, US2 gene, UL47-like gene. ORF4 gene; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
04/29/2008 | US7364892 Enhanced protease for use in detergents, leather treatment and animal feeds |
04/29/2008 | US7364891 Mutated alkaline cellulase |
04/29/2008 | US7364885 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
04/29/2008 | US7364883 Process for producing poly-unsaturated fatty acids by oleaginous yeasts |
04/29/2008 | US7364878 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements |
04/29/2008 | US7364877 Polynucleotides encoding disorazole polyketide synthase polypeptides |
04/29/2008 | US7364876 ADIP protein and use thereof |
04/29/2008 | US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
04/29/2008 | US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) |
04/29/2008 | US7364864 ANGE gene in atopy |
04/29/2008 | US7364858 genetic screening; multiplex detection; rapid single assay format |
04/29/2008 | US7364856 change in protein kinase activity in the recombinant bacterial cell contacted with the substance indicates the substance modulates activity; bioassay; drug screening; Tuberculosis; identifying modulator of a pknB protein kinase activity via its interaction with a ptsp2 phosphatase; antibacterial |
04/29/2008 | US7364853 Using variation in nucleotide repeat sequences as diagnostic indicators of cell proliferative disorders |
04/29/2008 | US7364852 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus |
04/29/2008 | US7364851 Nucleic acid sequencing by Raman monitoring of uptake of precursors during molecular replication |
04/29/2008 | US7364850 DNA probe array |
04/29/2008 | US7364848 Integrated microarray analysis |
04/29/2008 | US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
04/29/2008 | US7364846 Gene expression profiling from FFPE samples |
04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
04/29/2008 | US7364787 Lysosphingolipid obtained by treating sphingolipid mixture with sphingolipid ceramide N-deacylase for use in improving medicines and enhancing cell and carbohydrate engineering |
04/29/2008 | US7364750 Gene expression cassettes; transcription |
04/29/2008 | US7364745 Brucella melitensis strain deficient in the carboxyl-terminal proteolytic processing activity of a tail-specific protease caused by a nucleotide sequence deletion within a tspA gene; vaccine for swine, reindeer, cattle and humans; genetic engineering |
04/29/2008 | US7364740 Genetic deletions are used as markers to distinguish between pathogenic and avirulent strains such as Mycobacterium and Bacillus Calmette-Guerin (BCG); immunoassay; vaccines; attenuation, genetic engineering; immunogenic pure polypeptide encoded by a nucleotide sequence comprising open reading frame |
04/29/2008 | US7364739 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections |
04/29/2008 | US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections |
04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
04/29/2008 | US7364735 Method for diagnosis and treatment of haemophilia A patients with an inhibitor |
04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
04/29/2008 | US7364728 Genetically engineering organisms that produce proteins lethal to larvae of insects nucleotide sequences isolated from Bacillus popilliae encode two adjacent, putative genes; orf1 and cryhime; insecticides, larvicides, pesticides; beetles |
04/29/2008 | US7364727 Transcriptional regulatory element (TRE) sequence operably linked to virus replication gene; adenoviral vectors; selective cytotoxicity |